These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 5859903)

  • 41. [Isolation obligation and therapy in tuberculosis].
    Sybrecht GW
    Dtsch Med Wochenschr; 1997 Oct; 122(41):1265. PubMed ID: 9378057
    [No Abstract]   [Full Text] [Related]  

  • 42. Lipid biochemistry takes a stand against tuberculosis.
    Draper P
    Nat Med; 2000 Sep; 6(9):977-8. PubMed ID: 10973314
    [No Abstract]   [Full Text] [Related]  

  • 43. MORPHAZINAMIDE (PIAZOLINA) IN TREATMENT OF PULMONARY TUBERCULOSIS. (PRELIMINARY REPORT).
    ZIERSKI M
    G Ital Chemioter; 1963; 10():171-9. PubMed ID: 14085319
    [No Abstract]   [Full Text] [Related]  

  • 44. [Morphazinamede alone or associated in treatment of recent and chronic pulmonary tuberculosis. Observations on 48 cases].
    Baroni V; Sidari A
    Minerva Med; 1965 Sep; 56(71):2864-72. PubMed ID: 5322581
    [No Abstract]   [Full Text] [Related]  

  • 45. [Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1984 Mar; 112(3):290-5. PubMed ID: 6473971
    [No Abstract]   [Full Text] [Related]  

  • 46. [Operational aspects in the implementation of short-term antituberculous treatment].
    Pacheco CR
    Salud Publica Mex; 1985; 27(1):31-9. PubMed ID: 3992356
    [No Abstract]   [Full Text] [Related]  

  • 47. [Renal function in patients with minor forms of pulmonary tuberculosis in the course of treatment with 2d series drugs].
    Stepanenko VA
    Vrach Delo; 1972 Aug; 8():97-8. PubMed ID: 5073195
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis.
    Roy V; Tekur U; Chopra K
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):133-7. PubMed ID: 10091878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Short-course chemotherapy for tuberculosis in Chile. Operational considerations].
    Valenzuela P; Valenzuela MT
    Rev Med Chil; 1984 Mar; 112(3):287-9. PubMed ID: 6473970
    [No Abstract]   [Full Text] [Related]  

  • 51. Results of the second chemotherapy trial of the IUAT. Bacteriological part.
    Lind A; Rist N
    Bull Int Union Tuberc; 1968 Dec; 41():178. PubMed ID: 5710246
    [No Abstract]   [Full Text] [Related]  

  • 52. [RESULTS OBTAINED BY THE USE OF PYRAZINAMIDE AND MORPHAZINAMIDE IN AEROSOL ADMINISTRATION IN PNEUMOLOGY].
    KALLOS Z
    G Ital Chemioter; 1963; 10():180-9. PubMed ID: 14079400
    [No Abstract]   [Full Text] [Related]  

  • 53. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 54. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 55. Multiple small bowel perforations in a patient on treatment of tuberculosis.
    Scriven JM; Berry D
    J R Coll Surg Edinb; 1996 Oct; 41(5):353. PubMed ID: 8908966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [On the therapeutic use of piazofoline in pulmonary tuberculosis].
    Fici V; Fici G
    Minerva Med; 1966 Dec; 57(101):4375-6. PubMed ID: 5958227
    [No Abstract]   [Full Text] [Related]  

  • 57. Reappraisal of the activity of morphazinamide against M. tuberculosis.
    Bravo TC; Ellard GA; Mitchison DA
    Tubercle; 1975 Sep; 56(3):211-7. PubMed ID: 814663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [MORPHAZINAMIDE: THERAPEUTIC RESULTS AND EXPERIMENTAL INVESTIGATIONS].
    BESTA B
    G Ital Chemioter; 1963; 10():196-200. PubMed ID: 14079402
    [No Abstract]   [Full Text] [Related]  

  • 59. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of patients with pulmonary tuberculosis with antibacterial preparations of the second series].
    Vasilik GV
    Vrach Delo; 1967 Apr; 4():48-51. PubMed ID: 5612197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.